Research Report: Wake Up Call: Children With Diabetes Sleep Poorly

Researchers in Slovakia have found that kids with type 1 diabetes get poorer quality of sleep than their peers who do not have diabetes. Researchers studied 40 children–30 with type 1 diabetes and ten healthy controls without diabetes. … Read More

Research Report: Mini-Dose Glucagon New Treatment for Mild Hypoglycemia

A recent study found that a mini-dose of glucagon can be an effective treatment option for adults with type 1 diabetes dealing with mild hypoglycemia. Mini-dose glucagon treatments are especially beneficial because they do not require patients… Read More

Only 10% of Medicare ICD-10 Claims Rejected

On October 1, 2015, Medicare transitioned to using ICD-10 codes for processing claims. According to the Centers for Medicare & Medicaid Services (CMS), claims have been normally processing since this rollout. Approximately 10% of … Read More

High Court Upholds Health Law Subsidies

By Jay Hancock

The Affordable Care Act made it through its second do-or-die Supreme Court test in three years, raising odds for its survival but by no means ending the legal and political assaults on it’s five years after it became law.… Read More

Diabetes Drug May Reduce Alzheimer’s Disease

In the United States, the Centers for Disease Control and Prevention (CDC) estimates that as many as half of all Americans who are alive today will end their lives in nursing homes, although it won’t be because their bodies cease to function,… Read More

Research Report: Jardiance Reduces Cardiovascular Risk for Type 2 Diabetes

Boehringer Ingelheim and Eli Lilly and Company announced their primary results for the EMPA-REG outcome trial. The study showed that Jardiance® (empagliflozin), significantly reduces  the risk  for cardiovascular death,  … Read More

FDA Approves Two Novo Nordisk Insulin Medications

In late September 2015, the FDA finally approved Tresiba, a diabetes drug from Novo Nordisk. This once daily medication is a long-acting  drug that was previously rejected in 2013 after the FDA requested more data about the heart risks  … Read More